Lan Huang
Directeur Général chez BEYONDSPRING INC.
Fortune : 23 M $ au 30/04/2024
Postes actifs de Lan Huang
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| BEYONDSPRING INC. | Directeur Général | 01/11/2014 | - |
| Président | 01/11/2014 | - | |
| Fondateur | 01/01/2013 | - | |
Wuxi Mtlh Biotechnology Co. Ltd.
 Wuxi Mtlh Biotechnology Co. Ltd. Pharmaceuticals: MajorHealth Technology Wuxi Mtlh Biotechnology Co. Ltd. is a private company based in Wuxi, China that develops anti-cancer drugs. The Chinese company was founded by Lan Huang and Lan Huang has been the CEO since incorporation. | Directeur Général | 01/01/2010 | - |
| Fondateur | 01/01/2007 | - | |
BeyondSpring Pharmaceuticals, Inc.
 BeyondSpring Pharmaceuticals, Inc. BiotechnologyHealth Technology Part of BeyondSpring, Inc., BeyondSpring Pharmaceuticals, Inc. is a clinical-stage bio-pharmaceutical company that develops innovative immuno-oncology cancer therapies. The company is based in New York, NY. The company has a robust pipeline from internal development and collaboration with the University of Washington in de novo drug discovery using a ubiquitination platform. The CEO of the company is Lan Huang. | Directeur Général | - | - |
| Président | - | - | |
| Seed Therapeutics, Inc.(Pennsylvania) | Directeur Général | - | - |
| Président | - | - | |
| Fondateur | - | - | |
| Seed Therapeutics, Inc. | Directeur Général | - | - |
| Président | - | - | |
| Fondateur | - | - |
Historique de carrière de Lan Huang
Anciens postes connus de Lan Huang
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| Lawrence University | Directeur/Membre du Conseil | 01/01/2012 | 01/01/2015 |
| Dalian Wanchun Biotechnology Co. Ltd. | Fondateur | 01/01/2010 | - |
Paramax International, Inc.
 Paramax International, Inc. Medical/Nursing ServicesHealth Services Part of ICON plc, Paramax International, Inc. is a Chinese company that provides clinical research services. The company is based in Beijing, China. The company was founded by Lan Huang. Paramax International was acquired by ReSearch Pharmaceutical Services LLC, part of ICON plc from August 21, 2013 on July 07, 2009 for $1.53 million. | Fondateur | 01/01/2008 | - |
| Corporate Officer/Principal | 01/01/2008 | - |
Formation de Lan Huang
| Lawrence University | Undergraduate Degree |
| University of California, Berkeley | Doctorate Degree |
Statistiques
Internationale
| Etats-Unis | 7 |
| Chine | 4 |
Opérationnelle
| Founder | 6 |
| Chief Executive Officer | 5 |
| Chairman | 4 |
Sectorielle
| Health Technology | 4 |
| Consumer Services | 3 |
| Health Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| BEYONDSPRING INC. | Health Technology |
| Entreprise privées | 6 |
|---|---|
BeyondSpring Pharmaceuticals, Inc.
BeyondSpring Pharmaceuticals, Inc. BiotechnologyHealth Technology Part of BeyondSpring, Inc., BeyondSpring Pharmaceuticals, Inc. is a clinical-stage bio-pharmaceutical company that develops innovative immuno-oncology cancer therapies. The company is based in New York, NY. The company has a robust pipeline from internal development and collaboration with the University of Washington in de novo drug discovery using a ubiquitination platform. The CEO of the company is Lan Huang. | Health Technology |
Wuxi Mtlh Biotechnology Co. Ltd.
Wuxi Mtlh Biotechnology Co. Ltd. Pharmaceuticals: MajorHealth Technology Wuxi Mtlh Biotechnology Co. Ltd. is a private company based in Wuxi, China that develops anti-cancer drugs. The Chinese company was founded by Lan Huang and Lan Huang has been the CEO since incorporation. | Health Technology |
| Dalian Wanchun Biotechnology Co. Ltd. | |
| Seed Therapeutics, Inc. | |
| Seed Therapeutics, Inc.(Pennsylvania) | |
Paramax International, Inc.
Paramax International, Inc. Medical/Nursing ServicesHealth Services Part of ICON plc, Paramax International, Inc. is a Chinese company that provides clinical research services. The company is based in Beijing, China. The company was founded by Lan Huang. Paramax International was acquired by ReSearch Pharmaceutical Services LLC, part of ICON plc from August 21, 2013 on July 07, 2009 for $1.53 million. | Health Services |
